🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

February Nonfarm Payrolls 151K, Exp. 160K It’s a good thing everyone was overhedged for an awful jobs report because it was going to be horrific… oh wait

🚨Time to rethink the SCS trial-to-implant ratio?🚨 With recent implant rates >80%, are trial-to-implant ratios are still meaningful? Or is it time to update utilization metrics to include explant and per-capita ratios? Eellan Sivanesan, MD, FASA Ryan D'Souza, MD bit.ly/3QSdihN

Additive Or Synergistic Effects Of The Systemic And Perineural Routes Of Dexamethasone RCT, 104 patients, 3 groups. Intravenous dexamethasone: 37 Intravenous+perineural dexamethasone:34 Control:33 journals.lww.com/anesthesiology…

Systematic review highlights prevalence of chronic painful chemotherapy-induced peripheral neuropathy and its significant burden on patients. Very relevant to the PAINLESS study's patient-centered approach to pain management. rapm.bmj.com/content/early/… #CancerPain #Neuropathy

Great work by Nasir Hussain who joined experts from around the country in a systematic review and meta-analysis of data to determine better planning and treatment to address neuropathy in patients undergoing chemotherapy. Findings published in Regional Anesthesia & Pain Medicine ▶️ medicine.osu.edu/news/chemo-rel…

Superstar!! Congrats Johana Klasova 👏 So proud of your accomplishments and can’t wait to see you in residency!

In this editorial Jay Karri, MD, MPH and colleagues discuss Suzetrigine, a novel non-opioid analgesic targeting Nav1.8, that has recently gained FDA approval for moderate-to-severe acute pain. Read the full article here: bit.ly/44bIb8K Ryan D'Souza, MD

Suzetrigine, a novel non-opioid analgesic, has recently gained FDA approval for moderate-to-severe acute pain. While offering hope amid the opioid crisis, its ambiguous clinical benefits and trial limitations raise scrutiny. Jay Karri, MD, MPH Ryan D'Souza, MD bit.ly/44bIb8K

It’s 2025. We know the power of advanced pain medicine—from pharmaceuticals to regional anesthesia. Yet many hospitals still lack an ACUTE PAIN SERVICE. Healthcare is 17.6% of GDP. Money isn't the issue. Patients suffer. This must change. #MedTwitter ASRA Pain Medicine ASA Monitor

Intrathecal morphine is a mainstay for post-Caesarean analgesia. Ultrasound-guided #QL and #ESP blocks, but not #TAP block, can provide similar analgesia to IT morphine after #LSCS up to 12hr after surgery #RA bjanaesthesia.org/article/S0007-…

Want to learn how I make infographic content for Regional Anesthesia & Pain Medicine journal? Sign up for #ASRASpring25 #PBLD on May 1 where I will be breaking it down step-by-step with real examples and tips to level up your own visuals Dr. Vishal Uppal MBBS, FRCA 🇨🇦🇮🇳🏴󠁧󠁢󠁳󠁣󠁴󠁿 Sara Amaral, MD, EDRA, DESAIC Alopi Patel, M.D., FASA Siva Arumugam, MD, FASA Brian D. Sites, M.D., M.S.

Pain remains prevalent in cancer survivors who have #CIPN Check out this study👇🏾 🔗 doi.org/10.1136/rapm-2… Regional Anesthesia & Pain Medicine Mayo Clinic Department of Anesthesiology

Shout to Johns Hopkins for leading yesterday’s ASRA journal club! Pro-con debate on the use of liposomal bupivacaine. Dr. Kellie Jaremko as moderator, Dr. Kelly Kaneshiro and Dr. Reade Tillman as the presenters.

A new randomized controlled trial explores whether combining systemic with perineural dexamethasone yields any additive or synergistic effect on the characteristics and analgesic effects of peripheral nerve blocks. Read the article by Hussain et al.: ow.ly/71tU50W4c50

In a newly published editorial, Scott and Phan analyze research exploring the potential synergistic effects of dexamethasone via two routes (systemic and perineural) on block duration. Learn more: ow.ly/J0fr50W4eWQ

Which block for hip elective replacement ? This new network Meta in anesthesiology finds that periarticular infiltration alone provides the most consistent improvements in post-op rest pain, analgesic consumption, and functional recovery after THA. journals.lww.com/anesthesiology…

A new randomized controlled trial explores whether combining systemic with perineural dexamethasone yields any additive or synergistic effect on the characteristics and analgesic effects of peripheral nerve blocks. Learn more in Anesthesiology: ow.ly/bZca50WhEQC

“No benefit to adding Dexamethasone in perineural blocks” ✅ “Intravenous dose is good enough” Keep your blocks simple 🚫No additives ASRA Pain Medicine ASA® Society for Ambulatory Anesthesia (SAMBA) Ed Mariano, MD, MAS, FASA, FASRA 🇺🇸🇵🇭 🩺 Hari (హరి 🇮🇳) Kalagara Jeff Gadsden Renuka George MD, FASA Dr. Vishal Uppal MBBS, FRCA 🇨🇦🇮🇳🏴󠁧󠁢󠁳󠁣󠁴󠁿

🧠 Are scoping reviews in neuromodulation falling short? A new RAPM study found none of 7 reviews fully adhered to PRISMA-ScR. ⚠️ Protocols missing ⚠️ Methods vague ⚠️ Scoping ≠ narrative Time to raise the bar. 🔍 doi.org/10.1136/rapm-2… Ryan D'Souza, MD

🔌 Trial or no trial? New study in RAPM finds no clear advantage of temporary PNS trials vs direct-to-permanent implantation. 🧠 Similar pain relief 💊 Comparable opioid use 📖 doi.org/10.1136/rapm-2… Ryan D'Souza, MD Vinita Singh Jay Karri, MD, MPH Saba Javed, MD Nasir Hussain